Avid Bioservices Inc
Prices are adjusted according to historical splits.
Vitals
- Today's Low:
- $10.32
- Today's High:
- $10.73
- Open Price:
- $10.73
- 52W Low:
- $11.34
- 52W High:
- $21.05
- Prev. Close:
- $10.79
- Volume:
- 449151
Company Statistics
- Market Cap.:
- $985.12 million
- Book Value:
- 2.965
- Revenue TTM:
- $140.69 million
- Operating Margin TTM:
- 2.73%
- Gross Profit TTM:
- $36.65 million
- Profit Margin:
- 82.78%
- Return on Assets TTM:
- 0.63%
- Return on Equity TTM:
- 96.27%
Company Profile
Avid Bioservices Inc had its IPO on 2018-01-08 under the ticker symbol CDMO.
The company operates in the Healthcare sector and Biotechnology industry. Avid Bioservices Inc has a staff strength of 321 employees.
Stock update
Shares of Avid Bioservices Inc opened at $10.73 at the start of the last trading session i.e. 2023-09-12.
The stocks traded within a range of $10.32 - $10.73, and closed at $10.34.
This is a -4.17% slip from the previous day's closing price.
A total volume of 449,151 shares were traded at the close of the day’s session.
In the last one week, shares of Avid Bioservices Inc have slipped by -17.28%.
Avid Bioservices Inc's Key Ratios
Avid Bioservices Inc has a market cap of $985.12 million, indicating a price to book ratio of 4.9759 and a price to sales ratio of 6.3803.
In the last 12-months Avid Bioservices Inc’s revenue was $140.69 million with a gross profit of $36.65 million and an EBITDA of $10.58 million. The EBITDA ratio measures Avid Bioservices Inc's overall financial performance and is widely used to measure its profitability.
In the trailing 12-month period, Avid Bioservices Inc’s operating margin was 2.73% while its return on assets stood at 0.63% with a return of equity of 96.27%.
In Q0.33333333333333, Avid Bioservices Inc’s quarterly earnings growth was a negative -79.7% while revenue growth was a positive 20.7%.
Avid Bioservices Inc’s PE and PEG Ratio
- Forward PE
- 81.3008
- Trailing PE
- 9.2105
- PEG
Its diluted EPS in the last 12-months stands at $1.71 per share while it has a forward price to earnings multiple of 81.3008 and a PEG multiple of . A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.
The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Avid Bioservices Inc’s profitability.
Avid Bioservices Inc stock is trading at a EV to sales ratio of 7.4951 and a EV to EBITDA ratio of 98.5317. Its price to sales ratio in the trailing 12-months stood at 6.3803.
Avid Bioservices Inc stock pays annual dividends of $0 per share, indicating a yield of 0% and a payout ratio of 0%.
Balance sheet and cash flow metrics
- Total Assets
- $450.43 million
- Total Liabilities
- $87.32 million
- Operating Cash Flow
- $-11329000.00
- Capital Expenditure
- $11.33 million
- Dividend Payout Ratio
- 0%
Avid Bioservices Inc ended 2024 with $450.43 million in total assets and $0 in total liabilities. Its intangible assets were valued at $450.43 million while shareholder equity stood at $185.40 million.
Avid Bioservices Inc ended 2024 with $0 in deferred long-term liabilities, $87.32 million in other current liabilities, 62000.00 in common stock, $-430508000.00 in retained earnings and $0 in goodwill. Its cash balance stood at $59.92 million and cash and short-term investments were $59.92 million. The company’s total short-term debt was $3,024,000 while long-term debt stood at $140.36 million.
Avid Bioservices Inc’s total current assets stands at $132.34 million while long-term investments were $0 and short-term investments were $0. Its net receivables were $25.21 million compared to accounts payable of $36.39 million and inventory worth $45.10 million.
In 2024, Avid Bioservices Inc's operating cash flow was $-11329000.00 while its capital expenditure stood at $11.33 million.
Comparatively, Avid Bioservices Inc paid $0 in dividends in 2024.
Other key metrics
- Current Trading Price
- $10.34
- 52-Week High
- $21.05
- 52-Week Low
- $11.34
- Analyst Target Price
- $22.25
Avid Bioservices Inc stock is currently trading at $10.34 per share. It touched a 52-week high of $21.05 and a 52-week low of $21.05. Analysts tracking the stock have a 12-month average target price of $22.25.
Its 50-day moving average was $12.59 and 200-day moving average was $15.37 The short ratio stood at 15.53 indicating a short percent outstanding of 0%.
Around 67.8% of the company’s stock are held by insiders while 10913% are held by institutions.
Frequently Asked Questions About Avid Bioservices Inc
Similar Industry Stocks (Biotechnology)
Most Active
Top Gainers
Top Losers
About
Avid Bioservices, Inc., a contract development and manufacturing organization, provides process development and current good manufacturing practices (CGMP) clinical and commercial manufacturing services focused on biopharmaceutical drug substances derived from mammalian cell culture. The company produces monoclonal antibodies and recombinant proteins; and offers services, including CGMP clinical and commercial drug substance manufacturing, bulk packaging, release and stability testing, and regulatory submission and support. It also provides various process development services, such as upstream and downstream development and optimization, analytical methods development, testing, and characterization. The company serves biotechnology and biopharmaceutical industries. The company was formerly known as Peregrine Pharmaceuticals, Inc. and changed its name to Avid Bioservices, Inc. in January 2018. Avid Bioservices, Inc. was incorporated in 1981 and is headquartered in Tustin, California.